Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2002 6
2003 18
2004 8
2005 10
2006 13
2007 16
2008 12
2009 4
2010 2
2012 6
2013 6
2014 4
2015 8
2016 2
2017 3
2018 5
2019 4
2020 4
2021 3
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

128 results
Results by year
Filters applied: . Clear all
Page 1
Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease.
Egan MF, Kost J, Voss T, Mukai Y, Aisen PS, Cummings JL, Tariot PN, Vellas B, van Dyck CH, Boada M, Zhang Y, Li W, Furtek C, Mahoney E, Harper Mozley L, Mo Y, Sur C, Michelson D. Egan MF, et al. N Engl J Med. 2019 Apr 11;380(15):1408-1420. doi: 10.1056/NEJMoa1812840. N Engl J Med. 2019. PMID: 30970186 Free PMC article. Clinical Trial.
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease.
Egan MF, Kost J, Tariot PN, Aisen PS, Cummings JL, Vellas B, Sur C, Mukai Y, Voss T, Furtek C, Mahoney E, Harper Mozley L, Vandenberghe R, Mo Y, Michelson D. Egan MF, et al. N Engl J Med. 2018 May 3;378(18):1691-1703. doi: 10.1056/NEJMoa1706441. N Engl J Med. 2018. PMID: 29719179 Free PMC article. Clinical Trial.
From airway 'grading' to 'coding'.
Srinivasan K, Egan M. Srinivasan K, et al. Among authors: egan m. Eur J Anaesthesiol. 2021 Feb 1;38(2):205-206. doi: 10.1097/EJA.0000000000001314. Eur J Anaesthesiol. 2021. PMID: 33394803 No abstract available.
Verubecestat for Prodromal Alzheimer's Disease. Reply.
Kennedy ME, Egan MF. Kennedy ME, et al. Among authors: egan mf. N Engl J Med. 2019 Jul 25;381(4):389. doi: 10.1056/NEJMc1906679. N Engl J Med. 2019. PMID: 31340106 No abstract available.
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses.
Eldridge JH, Egan MA, Matassov D, Hamm S, Hermida L, Chen T, Tremblay M, Sciotto-Brown S, Xu R, Dimitrov A, Smith ER, Gurwith M, Chen RT; Benefit-Risk Assessment of VAccines by TechnolOgy Working Group BRAVATO, ex-V3SWG). Eldridge JH, et al. Among authors: egan ma. Vaccine. 2021 Sep 7;39(38):5436-5441. doi: 10.1016/j.vaccine.2021.07.030. Epub 2021 Aug 7. Vaccine. 2021. PMID: 34373117 Free article. Review.
Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease.
Wessels AM, Lines C, Stern RA, Kost J, Voss T, Mozley LH, Furtek C, Mukai Y, Aisen PS, Cummings JL, Tariot PN, Vellas B, Dupre N, Randolph C, Michelson D, Andersen SW, Shering C, Sims JR, Egan MF. Wessels AM, et al. Among authors: egan mf. Alzheimers Dement. 2020 Nov;16(11):1483-1492. doi: 10.1002/alz.12164. Epub 2020 Oct 13. Alzheimers Dement. 2020. PMID: 33049114 Clinical Trial.
Convergence of placenta biology and genetic risk for schizophrenia.
Ursini G, Punzi G, Chen Q, Marenco S, Robinson JF, Porcelli A, Hamilton EG, Mitjans M, Maddalena G, Begemann M, Seidel J, Yanamori H, Jaffe AE, Berman KF, Egan MF, Straub RE, Colantuoni C, Blasi G, Hashimoto R, Rujescu D, Ehrenreich H, Bertolino A, Weinberger DR. Ursini G, et al. Among authors: egan mf. Nat Med. 2018 Jun;24(6):792-801. doi: 10.1038/s41591-018-0021-y. Epub 2018 May 28. Nat Med. 2018. PMID: 29808008
Randomized, controlled, proof-of-concept trial of MK-7622 in Alzheimer's disease.
Voss T, Li J, Cummings J, Farlow M, Assaid C, Froman S, Leibensperger H, Snow-Adami L, McMahon KB, Egan M, Michelson D. Voss T, et al. Among authors: egan m. Alzheimers Dement (N Y). 2018 Apr 26;4:173-181. doi: 10.1016/j.trci.2018.03.004. eCollection 2018. Alzheimers Dement (N Y). 2018. PMID: 29955661 Free PMC article.
128 results